Search Tag: radiogenomics
2025 18 Nov
Cancers of the central nervous system (CNS) remain difficult to treat and insufficiently understood, with high morbidity and mortality. Artificial intelligence is moving into the neuro-oncological pathway, spanning prevention, diagnosis, treatment, prognostication and rehabilitation. Reported uses include image analysis, molecular characterisation,...Read more
2025 18 Nov
Cancers of the central nervous system (CNS) remain difficult to treat and insufficiently understood, with high morbidity and mortality. Artificial intelligence is moving into the neuro-oncological pathway, spanning prevention, diagnosis, treatment, prognostication and rehabilitation. Reported uses include image analysis, molecular characterisation,...Read more
2025 18 Nov
Cancers of the central nervous system (CNS) remain difficult to treat and insufficiently understood, with high morbidity and mortality. Artificial intelligence is moving into the neuro-oncological pathway, spanning prevention, diagnosis, treatment, prognostication and rehabilitation. Reported uses include image analysis, molecular characterisation,...Read more
2025 06 Jul
Hepatocellular carcinoma (HCC) is a major global health burden and ranks among the leading causes of cancer-related deaths. Despite curative treatments such as liver resection or transplantation, HCC exhibits high recurrence rates, often due to microvascular invasion (MVI), a pathological hallmark of tumour aggressiveness. Accurate preoperative...Read more
2024 25 Nov
Hepatocellular carcinoma (HCC) remains a significant global health challenge, ranking among the leading causes of cancer-related mortality. Despite advances in treatments, including surgery, systemic therapies and immunotherapies, survival rates for HCC patients remain low due to its aggressive nature and high recurrence rates. A major factor...Read more
2024 03 Nov
Lung cancer remains one of the most prevalent forms of cancer globally and is the leading cause of cancer-related mortality. Despite advancements in medical research, the overall survival (OS) rate for lung cancer patients continues to be low, underlining the urgent need for more accurate diagnostic and prognostic tools. When used separately,...Read more